ResultsIQ

ResultsIQ › Latest results › Novartis India Limited

Novartis India Limited Q2 FY27 results deck summary

NSE: NOVARTIND · BSE: 500672

Results deck of 3 Nov 2026, summarised by AI from the filing.

The shift to direct sales to stockists replaced the single-customer model, with 20+ CFAs and 2000+ stockists onboarded.

Key takeaways

  1. Model change The shift to direct sales to stockists replaced the single-customer model, with 20+ CFAs and 2000+ stockists onboarded.
  2. Portfolio adds The Minipress XL acquisition and an ophthalmology in-licensing agreement added cardiology and ophthalmology platforms.

Original filing on BSE

Novartis India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.